Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Omega 3 Market, by Type
1.4.2 North America Omega 3 Market, by Application
1.4.3 North America Omega 3 Market, by Source
1.4.4 North America Omega 3 Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Acquisition and Mergers
3.2.3 Product Launches and Product Expansions
3.2.4 Geographical Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2019, Nov – 2021, Feb) Leading Players
Chapter 4. North America Omega 3 Market by Type
4.1 North America Docosahexaenoic acid (DHA) Market by Country
4.2 North America Eicosapentaenoic acid (EPA) Market by Country
4.3 North America Alpha-linolenic acid (ALA) Market by Country
Chapter 5. North America Omega 3 Market by Application
5.1 North America Supplements & Functional Foods Market by Country
5.2 North America Pharmaceuticals Market by Country
5.3 North America Infant Formula Market by Country
5.4 North America Animal Feed & Pet Food Market by Country
5.5 North America Others Market by Country
Chapter 6. North America Omega 3 Market by Source
6.1 North America Marine Source Market by Country
6.2 North America Plant Source Market by Country
Chapter 7. North America Omega 3 Market by Country
7.1 US Omega 3 Market
7.1.1 US Omega 3 Market by Type
7.1.2 US Omega 3 Market by Application
7.1.3 US Omega 3 Market by Source
7.2 Canada Omega 3 Market
7.2.1 Canada Omega 3 Market by Type
7.2.2 Canada Omega 3 Market by Application
7.2.3 Canada Omega 3 Market by Source
7.3 Mexico Omega 3 Market
7.3.1 Mexico Omega 3 Market by Type
7.3.2 Mexico Omega 3 Market by Application
7.3.3 Mexico Omega 3 Market by Source
7.4 Rest of North America Omega 3 Market
7.4.1 Rest of North America Omega 3 Market by Type
7.4.2 Rest of North America Omega 3 Market by Application
7.4.3 Rest of North America Omega 3 Market by Source
Chapter 8. Company Profiles
8.1 Aker BioMarine AS
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Acquisition and Mergers:
8.2 GC Rieber VivoMega AS (GC Rieber group)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Recent strategies and developments:
8.2.3.1 Partnerships, Collaborations, and Agreements:
8.2.3.2 Product Launches and Product Expansions:
8.2.3.3 Geographical Expansions:
8.3 Epax Norway AS (Pelagia Holding AS)
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.4 FMC Corporation
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expenses
8.5 BASF SE
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Product Launches and Product Expansions:
8.6 Koninklijke DSM N.V.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.1 Recent strategies and developments:
8.6.1.1 Acquisition and Mergers:
8.7 Lonza Group AG
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.8 Orkla ASA (Orkla Health)
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.8.5.2 Acquisition and Mergers:
8.9 Croda International PLC
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 Recent strategies and developments:
8.9.5.1 Acquisition and Mergers:
8.10. Omega Protein Corporation (Cooke, Inc.)
8.10.1 Company Overview
Unique Offerings 